-
Kenya's economy faces climate change risks: World Bank
-
Danone expands recall of infant formula batches in Europe
-
EU nations back chemical recycling for plastic bottles
-
Why bitcoin is losing its luster after stratospheric rise
-
Stocks rebound though tech stocks still suffer
-
Digital euro delay could leave Europe vulnerable, ECB warns
-
German exports to US plunge as tariffs exact heavy cost
-
Stellantis takes massive hit for 'overestimation' of EV shift
-
'Mona's Eyes': how an obscure French art historian swept the globe
-
In Dakar fishing village, surfing entices girls back to school
-
Russian pensioners turn to soup kitchen as war economy stutters
-
As Estonia schools phase out Russian, many families struggle
-
Toyota names new CEO, hikes profit forecasts
-
Bangladesh Islamist leader seeks power in post-uprising vote
-
Japan to restart world's biggest nuclear plant
-
UK royal finances in spotlight after Andrew's downfall
-
Undercover probe finds Australian pubs short-pouring beer
-
New Zealand deputy PM defends claims colonisation good for Maori
-
Amazon shares plunge as AI costs climb
-
Deadly storm sparks floods in Spain, raises calls to postpone Portugal vote
-
Carney scraps Canada EV sales mandate, affirms auto sector's future is electric
-
Lower pollution during Covid boosted methane: study
-
Carney scraps Canada EV sales mandate
-
Record January window for transfers despite drop in spending
-
Mining giant Rio Tinto abandons Glencore merger bid
-
Davos forum opens probe into CEO Brende's Epstein links
-
ECB warns of stronger euro impact, holds rates
-
Greece aims to cut queues at ancient sites with new portal
-
ECB holds interest rates as strong euro causes jitters
-
What does Iran want from talks with the US?
-
Wind turbine maker Vestas sees record revenue in 2025
-
Bitcoin under $70,000 for first time since Trump's election
-
Germany claws back 59 mn euros from Amazon over price controls
-
Germany claws back 70 mn euros from Amazon over price controls
-
Stock markets drop amid tech concerns before rate calls
-
BBVA posts record profit after failed Sabadell takeover
-
UN human rights agency in 'survival mode': chief
-
Greenpeace slams fossel fuel sponsors for Winter Olympics
-
Russia says thwarted smuggling of giant meteorite to UK
-
Heathrow still Europe's busiest airport, but Istanbul gaining fast
-
Shell profits climb despite falling oil prices
-
German factory orders rise at fastest rate in 2 years in December
-
Trump fuels EU push to cut cord with US tech
-
Top US news anchor pleads with kidnappers for mom's life
-
The coming end of ISS, symbol of an era of global cooperation
-
New crew set to launch for ISS after medical evacuation
-
Stocks in retreat as traders reconsider tech investment
-
Fiji football legend returns home to captain first pro club
-
Barry Manilow cancels Las Vegas shows but 'doing great' post-surgery
-
Rising euro, falling inflation in focus at ECB meeting
E.coli can turn plastic into painkillers, chemists discover
Scientists have found a way to use the bacteria E.Coli to convert plastic waste into a popular painkiller, a study said Monday, though outside experts doubted the technique would make a dent in the fight against plastic pollution.
Paracetamol, which is one of the most commonly used drugs worldwide, is made from the derivatives of fossil fuels, often by Asia-based subcontractors using cheap, polluting methods that contribute to climate change.
The world is also facing an escalating crisis of plastic pollution, with countries set for another bruising round of negotiations in August in the hope of sealing an international treaty to reduce plastic waste.
The British team of researchers behind the new study sought to find a solution to the two problems by roping in a third -- E.coli, which is normally known for making people sick when they eat contaminated food.
First the chemists used a molecule derived from PET plastic, which is used in bottles and many other plastic products the world over, to spark a chemical reaction in a strain of E.coli.
This created a molecule they called PABA, according to the Nature Chemistry study, which was partly funded by drug firm AstraZeneca.
By genetically modifying the bacteria, the chemists were able to transform their molecule into acetaminophen, also known as paracetamol.
"This work demonstrates that PET plastic isn't just waste or a material destined to become more plastic -- it can be transformed by microorganisms into valuable new products, including those with potential for treating disease," lead study Stephen Wallace said in a statement.
Singaporean researchers not involved in the study praised how it combined synthetic and biological chemistry.
But "several practical considerations remain" to take this idea beyond the proof-of-concept stage, they wrote in a linked commentary in the journal Nature Chemistry.
The chemical reaction produces only a limited amount of PABA molecules, which "may be insufficient for industrial applications", they wrote.
Melissa Valliant, communications director of the Beyond Plastics project of Bennington College in the United States, expressed scepticism.
"A new 'plastic-eating bacteria' pops up in the news every few months and has been doing so for years," she told AFP.
"These discoveries never scale up to anything significant enough to tackle the massive plastic pollution problem."
This "crisis needs to be stopped at the source," she added, which means "companies and policymakers must reduce the amount of plastic being produced and used in the first place".
Y.Tengku--CPN